CompletedPhase 2NCT04300790

Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

Studying Hereditary breast cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
MedSIR
Principal Investigator
Antonio Llombart
MedSIR
Intervention
Alpelisib(drug)
Enrollment
69 enrolled
Eligibility
18 years · All sexes
Timeline
20202025

Study locations (19)

Collaborators

Novartis

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04300790 on ClinicalTrials.gov

Other trials for Hereditary breast cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary breast cancer

← Back to all trials